USE OF POTENT, SELECTIVE AND NON TOXIC C-KIT INHIBITORS FOR TREATING INTERSTITIAL CYSTITIS
The present invention relates to a method for treating interstitial cystitis, comprising administering a tyrosine kinase inhibitor to a human in need of such treatment, more particularly a non-toxic, potent and selective c-kit inhibitor, wherein said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.